We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Hospital-Based System Combines AI and Genomic Surveillance to Quickly Detect Infectious Disease Outbreaks

By LabMedica International staff writers
Posted on 28 Apr 2025

The current approach used by hospitals to detect and prevent the transmission of infectious diseases among patients is outdated. More...

These methods have remained largely unchanged for over a century. When two or more patients in a hospital exhibit nearly identical strains of an infection, it may be due to factors such as close proximity of hospital beds, shared medical equipment, or common healthcare providers. Typically, when clinicians notice that multiple patients have a similar infection, they notify the infection prevention team, which then reviews patient records to identify the possible source of transmission. This process is labor-intensive and often relies on busy healthcare workers identifying the shared infection between patients. While this may be feasible when patients are in the same unit, it becomes much harder to detect when patients are in different units with separate healthcare teams, and the only common factor is a visit to a procedure room. In such cases, the likelihood of detecting an outbreak before it spreads to other patients is significantly reduced. Now, a two-year trial has demonstrated that a new infectious disease detection platform can prevent outbreaks, save lives, and reduce costs for hospitals. The findings, published in Clinical Infectious Diseases, support the adoption of this system in U.S. hospitals and the creation of a national early outbreak detection database.

Researchers at the University of Pittsburgh School of Medicine (UPMC, Pittsburgh, PA, USA) have developed the Enhanced Detection System for Healthcare-Associated Transmission (EDS-HAT), which leverages increasingly affordable genomic sequencing to analyze infectious disease samples from patients. When the sequencing detects that two or more patients have nearly identical strains of an infection, it alerts the hospital’s infection prevention team, enabling them to identify the common source and halt the transmission. Without genomic sequencing, infection preventionists have no way of knowing if two patients are coincidentally infected with the same strain or if one patient was infected by the other. This lack of insight can result in infections spreading unnoticed when patients with similar infections have no obvious connection, such as being in the same unit, which allows outbreaks to grow before being detected.

On the other hand, infection preventionists may waste time and resources trying to prevent an outbreak that doesn’t exist when patients with the same infection have been exposed to unrelated sources. The study, conducted from November 2021 to October 2023 at UPMC Presbyterian Hospital, revealed that EDS-HAT prevented 62 infections and five deaths. It also resulted in savings of nearly USD 700,000 in infection treatment costs, providing a 3.2-fold return on investment. If healthcare facilities across the U.S. adopt EDS-HAT, a nationwide outbreak detection system could be established, similar to PulseNet, the U.S. Centers for Disease Control and Prevention’s network for identifying multistate outbreaks of foodborne illnesses. The researchers previously concluded that had such a system been in place, the 2023 outbreak of deadly bacteria linked to contaminated eye drops could have been detected and stopped much sooner.

“We saved lives while saving money. This isn’t theoretical – this happened in a real hospital with real patients,” said lead author Alexander Sundermann, Dr.P.H., assistant professor of infectious diseases in Pitt’s School of Medicine. “And it could easily be scaled. The more hospitals implement this practice, the more everyone benefits, not just by stopping previously undetected outbreaks within the walls of the hospital, but by finding medical device or medication-linked outbreaks sweeping the nation.”

Related Links:
UPMC 


New
Gold Member
Hybrid Pipette
SWITCH
Portable Electronic Pipette
Mini 96
New
Gold Member
Automated MALDI-TOF MS System
EXS 3000
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.